Retina Consultants of Hawaii

Summary

Retina Consultants of Hawaii is a medical facility located in Aiea, Hawaii. This center is recognized for care of Age-Related Macular Degeneration, Macular Degeneration, Diabetic Macular Edema, Cystoid Macular Edema, Choroidal Neovascularization and other specialties. Retina Consultants of Hawaii is involved with conducting 31 clinical trials across 27 conditions. There are 1 research doctors associated with this hospital, such as Gregg Kokame, MD.

Top PIs

Clinical Trials running at Retina Consultants of Hawaii

Age-Related Macular Degeneration

Macular Degeneration

Choroidal Neovascularization

Retinal Degeneration

Retinal Disease

None

Choroidal neovascularization

Wet AMD

Diabetic Retinopathy

Diabetic Macular Edema

RGX-314 Gene Therapy

for Age-Related Macular Degeneration

This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.

Recruiting

2 awards

Phase 3

2 criteria

4D-150 + EYLEA

for Age-Related Macular Degeneration

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Recruiting

2 awards

Phase 3

4 criteria

RGX-314 Gene Therapy

for Wet Age-Related Macular Degeneration

This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. It aims to help the eye make its own medicine to stop harmful blood vessels from causing vision loss. This could reduce the need for regular injections. RGX-314 modifies the retina's cells to create a treatment that may only be needed once.

Recruiting

1 award

Phase 2 & 3

6 criteria